TheEdgeResearch
Home / Stocks / CBLL

CeriBell, Inc. (CBLL)

NASDAQ Healthcare Medical - Devices
$27.39 ▲ +6.37%
Market Cap
$1.06B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.86
52-Wk Range
14.87-28.89
CEO
Xingjuan Chao
Country
US
Currency
USD

CeriBell, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sunnyvale, CA, US. The stock last traded at $27.39, up 6.37% on the session, giving a market capitalisation of $1.06B. On trailing twelve-month figures it carries a trailing P/E of -14.12, a net margin of -68.0%. Its beta of 0.86 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-14.12
Price / Sales
9.78
Price / Book
8.97
EV / EBITDA
-14.64
Gross margin
89.3%
Operating margin
-69.8%
Net margin
-68.0%
Return on equity
—
Debt / equity
0.18
Current ratio
8.18
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
327
IPO date
2024-10-11
Headquarters
Sunnyvale, CA, US
About CeriBell, Inc.

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Comparable companies

CeriBell, Inc. is most often compared with the following Healthcare names:

BWAYCVRXECORLIVNNMTCNPCESTIM
More research on CBLL
CBLL technical analysis CBLL TheEdge Score Compare against peers
Open full interactive analysis & DCF →